Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma injections can effectively treat stubborn alopecia areata.

The document reports the 19th global case of a rare skin condition in a patient from Colombia.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

Early diagnosis and treatment are crucial for managing alopecia areata, morphea, and psoriasis.

Hair and nail conditions can stabilize or improve over time, and new treatments show promise.

Intralesional triamcinolone acetonide can regrow hair in alopecia areata but often has temporary effects and side effects.

Covers common skin issues in kids, their diagnosis, treatment, and need for specialist care.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Voriconazole can cause serious side effects, especially in long-term use.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Niosomes are promising for skin drug delivery, offering benefits like improved drug penetration and stability.

Early onset and pustules indicate severe hair follicle inflammation, and while antibiotics help, the condition often worsens after treatment stops.

Folliculitis is an inflammation of hair follicles that requires proper diagnosis and treatment based on the specific cause.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Understanding facial anatomy and early management are key to preventing and treating complications from injectable fillers.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Polyesters show promise for repairing damaged blood vessels.

Thermoresponsive nanogels show promise for delivering medicine through the skin but need more safety testing and regulatory approval before clinical use.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

Managing frontal fibrosing alopecia and lichen planus pigmentosus is challenging due to resistant hair loss and skin discoloration.

Oral retinoids may help some patients with hard-to-treat lichen planopilaris, but more research is needed.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

An 84-year-old man got a rare scalp condition from using imiquimod cream, which was cured with systemic steroids.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

The document concludes that periocular hair disorders have various causes and treatments, and proper evaluation by specialists is important for management and prognosis.

Frontal Fibrosing Alopecia might be an autoimmune disease.

Older age is the main risk factor for hemorrhagic cystitis after stem cell transplants.